Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients with Solid Tumours

Trial Identifier: D0816C00025
Sponsor: AstraZeneca
Start Date: January 2020
Primary Completion Date: February 2025
Study Completion Date: February 2025
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Heidelberg, DE, 69120
DK København Ø, DK, 2100
ES Madrid, ES, 28009
FR Lille, FR, 59000
FR Toulouse, FR, 31300
FR Villejuif Cedex, FR, 94805
GB Glasgow, GB, G51 4TF
GB Sutton, GB, SM2 5PT
KR Seoul, KR, 03080
KR Seoul, KR, 05505